Washington Trust Advisors, Inc.
Position in SANA — Sana Biotechnology, Inc.
CIK 1900099
WELLESLEY, MA
Position in SANA
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$17,450
+$3,050 QoQ
Shares Held
5,000
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 39 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SANA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Washington Trust Advisors, Inc. holds $19,773,934 across 12 Biotechnology names. SANA ranks #6 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
27,703 | $17,273,928 | |
| 2 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
26,185 | $2,134,339 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
372 | $184,783 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
482 | $90,268 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
175 | $42,834 | |
| 6 | SANA |
Sana Biotechnology, Inc.
This page
|
5,000 | $17,450 | |
| 7 | INSM |
INSMED Inc
|
90 | $9,595 | |
| 8 | ARGX |
Argenx SE
|
8 | $7,422 |
All Filings in SANA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,450 | 5,000 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $14,400 | 5,000 | Shares | Sole | 2026-04-06 | |
| 2025-12-31 | $20,350 | 5,000 | Shares | Sole | 2026-02-03 | |
| No filing history on record for this holder in this stock. | ||||||